Cetuximab, capecitabine, and oxaliplatin (Cet-CapOx) with concurrent radiotherapy (RT) in advanced rectal cancer (RC): Results of a phase I/II trial

被引：0
|
作者：
Arnold, D.
Hipp, M.
Liersch, T.
Dellas, K.
Koelbl, O.
Hohenberger, W.
Lordick, F.
Suelberg, H.
Sauer, R.
Roedel, C.
机构：
[1] Martin Luther Univ Halle Wittenberg, Halle, Germany
[2] Univ Hosp, Regensburg, Germany
[3] George August Univ, Gottingen, Germany
[4] Friedrich Alexander Univ, Erlangen, Germany
[5] Tech Univ, Munich, Germany
[6] WiSP Inst, Langenfeld, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4042
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Preoperative Radiotherapy with Capecitabine, Oxaliplatin and Cetuximab in the Treatment of locally advanced Rectal Carcinoma: Long Term Results of a Phase II Study
    Weiss, C.
    Liersch, T.
    Arnold, D.
    Dellas, K.
    Hinke, A.
    Hipp, M.
    Balermpas, P.
    Roedel, F.
    Sauer, R.
    Roedel, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 122 - 122
  • [22] PREOPERATIVE RADIOTHERAPY OF ADVANCED RECTAL CANCER WITH CAPECITABINE AND OXALIPLATIN WITH OR WITHOUT CETUXIMAB: A POOLED ANALYSIS OF THREE PROSPECTIVE PHASE I-II TRIALS
    Weiss, Christian
    Arnold, Dirk
    Dellas, Kathrin
    Liersch, Torsten
    Hipp, Matthias
    Fietkau, Rainer
    Sauer, Rolf
    Hinke, Axel
    Roedel, Claus
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (02): : 472 - 478
  • [23] Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer
    Kathrin Dellas
    Thomas Höhler
    Thomas Reese
    Florian Würschmidt
    Erik Engel
    Claus Rödel
    Wolfgang Wagner
    Michael Richter
    Dirk Arnold
    Jürgen Dunst
    Radiation Oncology, 8
  • [24] Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer
    Dellas, Kathrin
    Hoehler, Thomas
    Reese, Thomas
    Wuerschmidt, Florian
    Engel, Erik
    Roedel, Claus
    Wagner, Wolfgang
    Richter, Michael
    Arnold, Dirk
    Dunst, Juergen
    RADIATION ONCOLOGY, 2013, 8
  • [25] Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II)
    Norifumi Hattori
    Goro Nakayama
    Keisuke Uehara
    Toshisada Aiba
    Kiyoshi Ishigure
    Eiji Sakamoto
    Yuichiro Tojima
    Mitsuro Kanda
    Daisuke Kobayashi
    Chie Tanaka
    Suguru Yamada
    Masahiko Koike
    Michitaka Fujiwara
    Masato Nagino
    Yasuhiro Kodera
    International Journal of Clinical Oncology, 2020, 25 : 118 - 125
  • [26] Prospective phase II trial of nimotuzumab in combination with radiotherapy and concurrent capecitabine in locally advanced rectal cancer
    Jin, Ting
    Zhu, Yuan
    Luo, Jia-Lin
    Zhou, Ning
    Li, De-Chuan
    Ju, Hai-Xin
    Fan, Yong-Tian
    Liu, Yong
    Zhu, Yu-Ping
    Feng, Hai-Yang
    Liu, Lu-Ying
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2015, 30 (03) : 337 - 345
  • [27] Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer
    Dunst, J
    Reese, T
    Sutter, T
    Zühlke, H
    Hinke, A
    Kölling-Schlebusch, K
    Frings, S
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (19) : 3983 - 3991
  • [28] Prospective phase II trial of nimotuzumab in combination with radiotherapy and concurrent capecitabine in locally advanced rectal cancer
    Ting Jin
    Yuan Zhu
    Jia-Lin Luo
    Ning Zhou
    De-Chuan Li
    Hai-Xin Ju
    Yong-Tian Fan
    Yong Liu
    Yu-Ping Zhu
    Hai-Yang Feng
    Lu-Ying Liu
    International Journal of Colorectal Disease, 2015, 30 : 337 - 345
  • [29] Phase II trial of preoperative capecitabine with concurrent radiotherapy in patients with locally advanced rectal cancer.
    Arias, F.
    de las Heras, M.
    del Moral, R.
    Gomez Millan, J.
    Jimenez, E.
    Wals, A.
    Alcantara, P.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S132 - S133
  • [30] Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II)
    Hattori, Norifumi
    Nakayama, Goro
    Uehara, Keisuke
    Aiba, Toshisada
    Ishigure, Kiyoshi
    Sakamoto, Eiji
    Tojima, Yuichiro
    Kanda, Mitsuro
    Kobayashi, Daisuke
    Tanaka, Chie
    Yamada, Suguru
    Koike, Masahiko
    Fujiwara, Michitaka
    Nagino, Masato
    Kodera, Yasuhiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (01) : 118 - 125
12345